The bottom line
Steadfast Nutrition's pharmaceutical positioning is credible in direction. The COA-on-request approach undermines it. At ₹18.3/dose, AS-IT-IS or MuscleBlaze offer better-documented creatine for less.
Steadfast Nutrition is an Indian sports nutrition brand that positions its products in the language of clinical nutrition — "Monograph" is the series name, implying pharmacopoeial specification. Their creatine monohydrate is correctly formulated at 5g per serving with no fillers. The brand claim of pharmaceutical-grade raw material sourcing is plausible but not independently verified in the public domain.
A COA is available on request. This is materially better than "no COA" and materially worse than "COA published on product page." For a brand whose identity is built around scientific credibility, the friction of requesting documentation creates a disconnect. Serious buyers will ask and receive the document. Most buyers will not ask, and will rely on the brand's pharmaceutical claim without verification.
The pricing does not help. At ₹18.3/dose, Steadfast costs more than MuscleBlaze CreaPRO (₹15.0, Creapure-certified) and substantially more than AS-IT-IS (₹9.2, NABL COA). You are paying an 18–99% premium for a product where the documentation gap is wider, not narrower, than cheaper alternatives.
What "pharmaceutical grade" means — and what it does not
The phrase "pharmaceutical grade" applied to a sports supplement ingredient requires scrutiny. In a regulated context, pharmaceutical grade refers to a substance manufactured under pharmaceutical GMP (Good Manufacturing Practice) per national or international pharmacopoeia standards (USP, IP, BP). This includes documentation requirements, contamination controls, stability testing, and batch traceability that exceed typical food supplement GMP.
However, "pharmaceutical grade" on a supplement label is not a regulated claim in India. FSSAI governs food supplements under food safety law, not drug law — and the phrase does not trigger any additional regulatory scrutiny or required certification. A brand can make this claim without providing a pharmacopoeial monograph test certificate, a facility audit, or any documentation beyond what a standard food supplement requires.
A pharmacopoeial monograph for creatine monohydrate (as in USP or IP) specifies identity, assay, impurities, and physicochemical parameters with defined test methods and acceptance criteria. "Monograph" as a branding word is evocative of this standard. Whether Steadfast's creatine is tested against a pharmacopoeial monograph test method — with documentation — is the question the COA would answer. Request the COA before purchasing if this distinction matters to you.
Label analysis
Steadfast Monograph Creatine contains creatine monohydrate as the sole ingredient. The label is clean — no proprietary blend, no fillers, no sweeteners in the unflavoured format. The 5g scoop is correctly sized. The "Monograph" branding and "pharmaceutical grade supply" language are prominently featured. The label does not specify the raw material source or provide a test method reference.
The brand's overall positioning is aimed at sports dietitians, hospitals, and athletes who want clinical-adjacent nutrition — Steadfast also makes products for clinical supplementation (not just sports). This context makes the COA-on-request approach particularly incongruous: the clinical market expects documentation as standard, not as a concession to a specific buyer's request.
Dosing
Steadfast recommends 1 scoop (5g) daily. This matches the evidence-based maintenance dose. Loading (20g/day for 5–7 days) is not specifically recommended on the label but is consistent with the product's formulation and any generic creatine loading protocol.
The sachet format (individual 5g sachets are available separately from Steadfast, though the 300g tub is what most buyers use) has a practical advantage: individual portion control without a scale. If you are supplementing creatine while travelling and cannot bring a full tub, the sachet format simplifies logistics. This is a niche advantage but a real one for the Steadfast buyer profile.
Value: premium without the documentation to justify it
| Product | Per dose | Documentation | Source |
|---|---|---|---|
| AS-IT-IS Creatine | ₹9.2 | NABL COA (published) | Undisclosed, domestic |
| MuscleBlaze CreaPRO | ₹15.0 | Creapure certification | AlzChem, Germany |
| Steadfast Monograph | ₹18.3 | COA on request | Pharmaceutical grade (claimed) |
| GNC Pro Performance | ₹21.7 | Creapure certification | AlzChem, Germany |
At ₹18.3/dose, Steadfast is priced between MuscleBlaze CreaPRO and GNC Pro Performance. Both of those options provide stronger independent documentation than COA-on-request. The Steadfast premium is not supported by its transparency infrastructure.
Contact Steadfast Nutrition customer support and request the batch COA for your specific tub lot number. They provide it. Reviewing the document lets you verify the analytical method, the testing lab, and the results — and gives you the independent confirmation the label positioning implies but the public-facing documentation does not currently provide.
Who this is for
Consider if: You work with a sports dietitian or clinician who recommends Steadfast products across their patient/athlete population, and you want a consistent product in a brand ecosystem you are already using. The formulation is correct. The COA exists if you ask.
Consider if: You buy supplements through hospital or clinical channels where Steadfast has a distribution relationship, and you value the brand's clinical positioning and supply infrastructure.
Not recommended if: Value is a priority. At ₹18.3/dose, you are paying more than you need to for a product where stronger documented alternatives exist at lower prices.
Not recommended if: You want passively verifiable purity documentation. COA-on-request means the information exists but requires active effort to access. AS-IT-IS publishes a NABL COA directly on their product page — no friction, same ingredient, ₹9.1/dose cheaper.
Our score — rubric breakdown
Creatine monohydrate. The ingredient evidence base is identical across all monohydrate products — more than 1,000 RCTs, consistent effect on PCr resynthesis and resistance training volume. Brand does not affect this score.
Creatine monohydrate, correct form. Single ingredient, correct dose. Particle size is unstated — standard vs micronized is not specified. Minor deduction for this gap, consistent with other domestic products that do not specify particle size.
COA available on request is a meaningful step above "no documentation." The pharmaceutical-grade sourcing claim is directionally positive — the supply chain orientation is a genuine differentiator if it holds. But the documentation is not publicly verifiable: no public lab name, no public test reference, no NABL or Creapure anchoring. Score reflects the gap between claim and independently accessible evidence.
₹18.3/dose is above MuscleBlaze CreaPRO (₹15/dose, Creapure-certified) and well above AS-IT-IS (₹9.2/dose, NABL COA). Neither competitor requires COA request friction. The Steadfast premium is not justified by the current documentation posture relative to these alternatives.
Single-ingredient label, correct dose, no proprietary blend. The "pharmaceutical grade supply" and "Monograph" language is not a lie — it is a claim that the COA should substantiate. The deduction is for the gap between the clinical-scientific brand positioning and the public documentation that supports it. If Steadfast published the COA proactively, this score would move to 8.5.
Score formula: (9.5 × 0.30) + (8.0 × 0.20) + (6.0 × 0.20) + (4.5 × 0.15) + (7.0 × 0.15) = 2.85 + 1.60 + 1.20 + 0.675 + 1.05 = 7.375 → 7.4 / 10
References
- Kreider RB, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr. 2017;14:18.
- Rawson ES, Volek JS. Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance. J Strength Cond Res. 2003;17(4):822–831.
- FSSAI. Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2022. fssai.gov.in. Accessed Jul 2026.
- United States Pharmacopoeia. Creatine Monohydrate monograph. usp.org. Accessed Jul 2026.
- Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80(3):1107–1213.